Lincoln Pharmaceuticals Ltd
NSE:LINCOLN
Lincoln Pharmaceuticals Ltd
NSE:LINCOLN
Price:
634.6
INR
3.07%
Market Cap:
₹12.7B
Relative Value
The Relative Value of one
LINCOLN
stock under the Base Case scenario is
653.64
INR.
Compared to the current market price of 634.6 INR,
Lincoln Pharmaceuticals Ltd
is
Undervalued by 3%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
LINCOLN
Relative Value
Base Case
653.64
INR
Undervaluation 3%
Multiples Across Competitors
LINCOLN Competitors Multiples
Lincoln Pharmaceuticals Ltd Competitors
Lincoln Pharmaceuticals Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IN |
|
Lincoln Pharmaceuticals Ltd
NSE:LINCOLN
|
12.8B INR | 1.9 | 14.5 | 10.5 | 12.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
961.6B USD | 14.8 | 46.6 | 31.4 | 33.4 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
588.7B USD | 6.2 | 22 | 15.2 | 18.7 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
295B CHF | 4.8 | 31.4 | 13.2 | 15.4 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
242.6B GBP | 5.6 | 32.3 | 17.8 | 25.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
248.1B CHF | 5.7 | 22.8 | 14 | 18 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
301.6B USD | 4.6 | 16.5 | 10.3 | 12.1 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.4 | 13.4 | 9.8 | 11.5 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
155.7B USD | 2.5 | 20 | 7.5 | 10 | |
| UK |
|
GlaxoSmithKline PLC
LSE:GSK
|
92.5B GBP | 2.8 | 16.2 | 8.1 | 11.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
